Efficacy of varenicline or bupropion and its association with nicotine metabolite ratio among smokers with COPD

伐尼克兰 安非他酮 医学 尼古丁 慢性阻塞性肺病 代谢物 药理学 戒烟 内科学 病理
作者
Rui Qin,Zhao Liu,Anqi Cheng,Xinmei Zhou,Zheng Su,Ziyang Cui,Jinxuan Li,Xiaowen Wei,Liang Zhao,Kian Fan Chung,Dan Xiao,Chen Wang
出处
期刊:Respirology [Wiley]
卷期号:29 (6): 479-488 被引量:4
标识
DOI:10.1111/resp.14702
摘要

Abstract Background and objective Nicotine metabolic ratio (NMR) has been associated with nicotine metabolism and smoking characteristics. However, there are few studies on the potential association between NMR and smoking cessation efficacy in smokers with chronic obstructive pulmonary disease (COPD) in China or elsewhere. Methods This study was a stratified block randomized controlled trial for smoking cessation in Chinese smokers with COPD. NMR was used as a stratification factor; slow metabolizers were defined as those with NMR <0.31, and normal metabolizers as those with NMR ≥0.31. Participants were randomly assigned to the varenicline or bupropion group. Follow‐up visits were conducted at 1, 2, 4, 6, 9, 12 and 24 weeks. Results Two hundred twenty‐four participants were recruited and analysed from February 2019 to June 2022. In normal metabolizers, the 9–12 weeks continuous abstinence rate of varenicline (43.1%) was higher than in bupropion (23.5%) (OR = 2.47, 95% CI 1.05–5.78, p = 0.038). There was no significant difference in abstinence rates between treatment groups in slow metabolizers (54.1% vs. 45.9%, OR = 1.39, 95% CI 0.68–2.83, p = 0.366). For slow metabolizers, the total score of side effects in the varenicline group was significantly higher than the bupropion group ( p = 0.048), while there was no significant difference in side effects between groups for normal metabolizers ( p = 0.360). Conclusion Varenicline showed better efficacy than bupropion in normal metabolizers, and bupropion showed equivalent efficacy in slow metabolizers with less side effects. According to our study, NMR provides a better justification for both scientific research and tailoring optimal pharmacotherapy for smoking cessation among smokers in COPD.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
常常完成签到 ,获得积分10
1秒前
lx发布了新的文献求助10
1秒前
1秒前
SSY完成签到,获得积分10
3秒前
祗想静静嘚完成签到 ,获得积分10
3秒前
zzw完成签到,获得积分10
3秒前
苏黎世发布了新的文献求助10
3秒前
李大柱完成签到,获得积分10
3秒前
David完成签到,获得积分10
4秒前
周欣玙发布了新的文献求助10
4秒前
net80yhm发布了新的文献求助10
5秒前
NCU-Xzzzz完成签到,获得积分10
5秒前
拼搏一曲完成签到 ,获得积分10
6秒前
荒野风发布了新的文献求助10
6秒前
轻松的鸿煊完成签到 ,获得积分10
7秒前
NCU-Xzzzz发布了新的文献求助10
7秒前
9秒前
JJG完成签到,获得积分20
10秒前
Hello应助Tiam采纳,获得10
11秒前
11秒前
ty完成签到,获得积分10
13秒前
zehua309完成签到,获得积分10
14秒前
火星上含芙完成签到 ,获得积分10
15秒前
量子星尘发布了新的文献求助10
17秒前
17秒前
掌门发布了新的文献求助10
17秒前
愉快的花卷完成签到,获得积分10
17秒前
少言完成签到,获得积分10
19秒前
kiko完成签到,获得积分10
20秒前
隐形惜筠完成签到 ,获得积分10
22秒前
黑眼圈完成签到,获得积分10
26秒前
123发布了新的文献求助10
28秒前
29秒前
30秒前
又又妈妈完成签到,获得积分10
30秒前
欢呼的丁真完成签到,获得积分10
31秒前
ty发布了新的文献求助10
31秒前
Faded完成签到 ,获得积分10
32秒前
ding应助Amorfati采纳,获得10
32秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
Research on Disturbance Rejection Control Algorithm for Aerial Operation Robots 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038524
求助须知:如何正确求助?哪些是违规求助? 3576221
关于积分的说明 11374737
捐赠科研通 3305912
什么是DOI,文献DOI怎么找? 1819354
邀请新用户注册赠送积分活动 892688
科研通“疑难数据库(出版商)”最低求助积分说明 815048